Login / Signup

Post-market utilization patterns of Alzheimer's disease treatments in South Korea: comparison with countries with universal health coverage.

Hye-Jae LeeElizabeth Ellen RougheadEuna HanJihye LeeLisa Kalisch Ellett
Published in: European journal of clinical pharmacology (2021)
Despite the similar UHC systems, there were considerable differences in the post-market utilization of AD treatments in Korea from Australia and other countries. This results can be attributed to differences in re-assessment system, pricing and reimbursement policies, and prescribing culture. This study provides a baseline to explore more comprehensive cross-country studies on rational use of medicines.
Keyphrases
  • public health
  • health insurance
  • healthcare
  • primary care
  • cognitive decline
  • affordable care act
  • emergency department
  • risk assessment
  • case control
  • mild cognitive impairment